Showing results (491-500 of 847) with videos related to

Sort By:
Pageof 85
JNCI Cancer Spectrum|October 21, 2022
Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant CarriersMichael R Sargen, Hildur Helgadottir, Xiaohong R Yang, et al.
JNCI Cancer Spectrum|March 18, 2021
Association of Daily Alcohol Intake, Volumetric Breast Density, and Breast Cancer RiskAlison S Rustagi, Christopher G Scott, Stacey J Winham, et al.
JNCI Cancer Spectrum|January 10, 2022
The Prevalence of Dissemination and Implementation Research and Training Grants at National Cancer Institute-Designated Cancer CentersNora M Mueller, Ada Hsieh, Shoba Ramanadhan, et al.
JNCI Cancer Spectrum|November 2, 2022
Psychiatric Disorder Incidence Among Adolescents and Young Adults Aged 15-39 With Cancer: Population-Based CohortBrianna K Rosgen, Stephana J Moss, Kirsten M Fiest, et al.
JNCI Cancer Spectrum|October 18, 2022
The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate CancerDaniel D Joyce, Christopher J D Wallis, Li-Ching Huang, et al.
JNCI Cancer Spectrum|October 18, 2022
Impact of Clinical Data Veracity on Cancer Genomic ResearchSunali Mehta, Deborah Wright, Michael A Black, et al.
JNCI Cancer Spectrum|September 23, 2022
Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World DataPritish Iyer, Mengying Deng, Elizabeth A Handorf, et al.
JNCI Cancer Spectrum|October 14, 2022
Spatial-Temporal Trends in Ovarian Cancer Outcomes in CaliforniaCarolina Villanueva, Jenny Chang, Argyrios Ziogas, et al.
JNCI Cancer Spectrum|October 7, 2022
Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal CancerCharles E Gaber, Nicholas J Shaheen, Jessie K Edwards, et al.
JNCI Cancer Spectrum|January 20, 2022
Racial Disparities in Access to Prostate Cancer Clinical Trials: A County-Level AnalysisWei-Jhih Wang, Scott David Ramsey, Caroline Savage Bennette, et al.
Pageof 85